Navigation Links
Study Raises New Questions About Cholesterol Drug Zetia
Date:11/16/2009

It was found less effective than extended-release niacin, or Niaspan

SUNDAY, Nov. 15 (HealthDay News) -- A new study raises more questions about ezetimibe (Zetia), a drug used by millions of Americans in tandem with statins to lower LDL, or "bad," cholesterol.

The trial, known as ARBITER-6 HALTS, was stopped early in June after it was discovered that LDL-cholesterol-lowering Zetia was less effective than extended-release niacin (Niaspan), which raises HDL, or "good," cholesterol levels, in reducing plaque build-up in the arteries.

Clinical trials are generally terminated early if a safety issue arises, less so when a measure of success is achieved.

The niacin combination also reduced the number of heart attacks and deaths.

"This trial provides a clear and undeniable statement on the superior clinical effectiveness of niacin over ezetimibe," study principal investigator Dr. Allen Taylor, director of Advanced Cardiovascular Imaging and the Lipid/Prevention Clinic at Washington Hospital Center in Washington, D.C., said at a Sunday afternoon news conference.

The study was funded by the pharmaceutical company Abbott Laboratories, which makes Niaspan, and Taylor and other study authors have received consulting fees from the company. Merck & Co. makes Zetia.

Taylor presented the findings at the American Heart Association's annual meeting in Orlando, Fla. The report was also released early online Nov. 16 in the New England Journal of Medicine.

"This trial showed the clear superiority of niacin over ezetimibe. I would say that the combination of LDL-lowering and HDL-increasing with niacin was associated with a greater regression of atherosclerosis," added Dr. John J.P. Kastelein, author of one of two editorials accompanying the paper. Kastelein is with the department of vascular medicine, Academic Medical Center, Meibergdreef, the Netherlands.

The current eviden
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... Excellence in Reporting, Portrayals of Mental Health Issues; ... ,, ALEXANDRIA, Va. , Feb. ... journalists and media professionals to submit national, state, ... print, online radio, television and film for the ... a downloadable entry form, are available at ...
(Date:2/9/2010)... Sheila Doss , BSN, RN, CNN, ... re-elected Western Chapters Coordinator-Elect (CCE) of the American ... Doss, Nursing Director of Research of Satellite Healthcare will ... in San Antonio, TX , May ... coordinate and supervise regional chapter activities, report to the ...
(Date:2/9/2010)... and Stimulus Resource Library featured on redesigned MxSecure, Inc. site: ... ... AZ (PR WEB) February 9, 2010 -- Medical transcription ... the launch of their new website., , , , ,Improving ... MxSecure,s revamped website, and it captures the focus of all ...
(Date:2/9/2010)... Benefits American Heart Association’s Go Red For Women® Movement to ... Counties. , ... Central Coast, CA ... San Luis Obispo and Santa Barbara Counties announce their participation ... Life campaign that launched on February 1, 2010. Benefiting ...
(Date:2/9/2010)... Manhattan Research’s Health Influence Mapping Research Module Helps Marketers ... Consumer Health Behavior , ... ... February 9, 2010 -- The Internet has considerably more ... channels like print, TV and radio, according to pharmaceutical ...
Breaking Medicine News(10 mins):Health News:Mental Health America Encourages Journalists, Media Professionals to Submit Entries for 2010 Media Awards 2Health News:Mental Health America Encourages Journalists, Media Professionals to Submit Entries for 2010 Media Awards 3Health News:Satellite Healthcare's Sheila Doss Elected Western Chapters Coordinator-Elect of the American Nephrology Nurses' Association 2Health News:Satellite Healthcare's Sheila Doss Elected Western Chapters Coordinator-Elect of the American Nephrology Nurses' Association 3Health News:Medical Transcription Services and EHR Provider MxSecure Launches New Enhanced Website with Goal of Improved Physician Productivity 2Health News:Central Coast Jiffy Lube Service Centers Embark on Year Three of Successful Maintenance Partners For Life Campaign 2Health News:Central Coast Jiffy Lube Service Centers Embark on Year Three of Successful Maintenance Partners For Life Campaign 3Health News:Central Coast Jiffy Lube Service Centers Embark on Year Three of Successful Maintenance Partners For Life Campaign 4Health News:New Report: The Internet Has More Influence Over Consumer Health Actions than Traditional DTC Channels 2Health News:New Report: The Internet Has More Influence Over Consumer Health Actions than Traditional DTC Channels 3Health News:New Report: The Internet Has More Influence Over Consumer Health Actions than Traditional DTC Channels 4Health News:New Report: The Internet Has More Influence Over Consumer Health Actions than Traditional DTC Channels 5
... doctors in St Helens Hospital, Tasmania have been blamed on ... Excessive workload was the reason given by most doctors for ... Cerchez there have been more doctors recruited to St Helens ... high turnover is to internal issues. , He ...
... dishes in the menu of the Aiwan-e-Sadar, President's House, ... told the National Assembly that chicken dishes have been ... where foreigners and diplomats are invited. This is part ... he said in a reply to a question. ...
... of vitamin C and E supplements during pregnancy in no ... in healthy women//. ,Preeclampsia is a condition in ... pregnancy elevated blood pressure at a level that could potentially ... ,According to foodconsumer.org, the study of nearly 2000 women in ...
... water filtration system, powered by bicycle that can be ... (NTU) institute of environmental science and engineering unveiled the ... pump and a membrane module to filter the water. ... experts said it is an improvement on the hand-cranked ...
... to for help with their weight problems. According to a ... the obese in getting back to shape. Incidentally, Oxyntomodulin is ... feelings of satiation, or Feeling Full. , ,Steve Bloom ... men and women. The study participants belonged to the age ...
... in ducks on Indonesia's resort island of Bali, health ... had been smuggled to Bali from the adjacent Java ... ,More than 24 bird flu related deaths ... nation. In response to the above situation, import of ...
Other Medicine News:Health News:Preeclampsia Risk Can't Be Overcome By Taking Antioxidants 2Health News:Hormone - A Shot in the Arm for Weight Loss 2
(Date:2/9/2010)... The Netherlands , February 9 ... as CEO of Hoya Vision Care,Europe starting the 1st of ... Gerald W.,Bottero , who has been leading the European branch ... Hoya Vision Care globally. ,, Mr. ... is,currently President of Hoya Lens Belgium and Hoya Lens France. ...
(Date:2/9/2010)... Feb. 9 Sanofi-aventis (EURONEXT: SAN ... it has successfully completed its tender offer for all ... CHTT).   ,, The tender offer and withdrawal rights ... time, on February 8, 2010 .  The depositary ... of the expiration time, approximately 18,611,072 shares of Chattem ...
(Date:2/8/2010)... , Feb. 8 Cost reductions ... Products (Nasdaq: AHPI ) narrowly back into profitability ... Sales for the quarter ended December 31, 2009 ... million during the same quarter last year to ... Allied,s costs of sales were reduced even more sharply, ...
Breaking Medicine Technology:New CEO for Hoya Vision Care Europe 2Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc. 2Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc. 3Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc. 4Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc. 5Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 2Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 3Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 4Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 5Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 6St Elizabeth Healthcare Drives Kentuckys Largest Electronic Medical Records Initiative With IBM 53145 1St Elizabeth Healthcare Drives Kentuckys Largest Electronic Medical Records Initiative With IBM 53145 2St Elizabeth Healthcare Drives Kentuckys Largest Electronic Medical Records Initiative With IBM 53145 3Roxane Laboratories Inc Announces the Launch of Risperidone Oral Solution 1mg mL 53140 1Roxane Laboratories Inc Announces the Launch of Risperidone Oral Solution 1mg mL 53140 2Neurocrine Biosciences Reports Second Quarter 2009 Results 13258 1Neurocrine Biosciences Reports Second Quarter 2009 Results 13258 2Neurocrine Biosciences Reports Second Quarter 2009 Results 13258 3Neurocrine Biosciences Reports Second Quarter 2009 Results 13258 4Neurocrine Biosciences Reports Second Quarter 2009 Results 13258 5Neurocrine Biosciences Reports Second Quarter 2009 Results 13258 6Neurocrine Biosciences Reports Second Quarter 2009 Results 13258 7
... UCB offers Cimzia(R) (certolizumab pegol), a treatment option ... arthritis and moderate to severe Crohn,s disease, to ... resulting from the UCB partnership with OXO(R) ... and OXO(R) in the development of the new ...
... U.S.D.A. Animal Studies: Chromium Picolinate and Chromium Histidinate ... Studies Continue to Demonstrate Safety and Efficacy of ... Nutrition 21, Inc. (Nasdaq: NXXI ... under the Iceland Health(R) and Diabetes Essentials brands, ...
Other Medicine Technology:Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 2Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 3Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 4Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 5Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 6Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 7Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 8Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 9Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 10Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 11New Research Shows Nutrition 21's Chromium Histidinate Improves Markers for Mood and Carbohydrate Cravings 2New Research Shows Nutrition 21's Chromium Histidinate Improves Markers for Mood and Carbohydrate Cravings 3New Research Shows Nutrition 21's Chromium Histidinate Improves Markers for Mood and Carbohydrate Cravings 4
This Wright-Giemsa is a dual-use stain for peripheral blood and bone marrow smears. It produces somewhat darker results when compared with Giemsa, particularly in the blue to magenta shades....
RABIT (Rapid Automated Bacterial Impedance Technique) has been developed by Don Whitley Scientific over several years with the aid of leading product and computer design consultants....
Albumin FS for determination of albumin in serum or plasma. For Hitachi 704 / 911. Available with Calibrator: Trucal U and Controls: Trulab N and Trulab P....
Intended for the quantitative determination of albumin in serum or plasma. Reaction: Endpoint. Wavelength: 628 nm. Linearity: 8 g/dl (80 g/l). Ready to use liquid reagent....
Medicine Products: